Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21149918

Download in:

View as

General Info

PMID
21149918